Intuitive Surgical, Inc.
ISRGNASDAQ
$449.81
Last price · USD
- Market cap
- $163.1B
- P/E
- 57.2x
- EV / EBITDA
- 40.1x
- P/S
- 16.2x
- FCF yield
- 1.5%
- Div. yield
- 0.00%
Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.
Intuitive Surgical, Inc. key metrics & ratios
Annual · USD millions except per-share data · 35 lines
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | CAGR | |
|---|---|---|---|---|---|---|---|
| Growth (year over year) | |||||||
| Revenue growth | 20.5% | 17.2% | 14.5% | 9.0% | — | — | |
| Operating income growth | 25.4% | 32.9% | 12.0% | -13.4% | — | — | |
| Net income growth | 23.0% | 29.2% | 36.0% | -22.4% | — | — | |
| EPS (diluted) growth | 22.6% | 27.6% | 37.8% | -21.7% | — | — | |
| Free cash flow growth | 91.0% | 73.9% | -21.8% | -44.8% | — | — | |
| Margins | |||||||
| Gross margin | 66.0% | 67.5% | 66.4% | 67.4% | 69.3% | — | |
| Operating margin | 29.3% | 28.1% | 24.8% | 25.3% | 31.9% | — | |
| EBITDA margin | 39.6% | 37.5% | 33.9% | 31.7% | 38.5% | — | |
| Net margin | 28.4% | 27.8% | 25.2% | 21.3% | 29.9% | — | |
| FCF margin | 24.7% | 15.6% | 10.5% | 15.4% | 30.4% | — | |
| Returns on capital | |||||||
| Return on equity | 16.0% | 14.1% | 13.5% | 12.0% | 14.3% | — | |
| Return on assets | 13.8% | 12.3% | 11.6% | 10.2% | 12.6% | — | |
| Return on invested capital | 17.3% | 14.1% | 15.5% | 13.9% | 15.5% | — | |
| Leverage & liquidity | |||||||
| Debt / equity | 0.02x | 0.01x | 0.00x | 0.00x | 0.01x | — | |
| Net debt / EBITDA | -0.77x | -0.60x | -1.14x | -0.80x | -0.55x | — | |
| Current ratio | 4.87x | 4.07x | 4.76x | 4.40x | 5.08x | — | |
| Profitability & operating | |||||||
| EBIT | 3,311 | 2,674 | 1,959 | 1,607 | 1,890 | +15.0% | |
| EBITDA | 3,989 | 3,136 | 2,414 | 1,973 | 2,201 | +16.0% | |
| Operating income | 2,946 | 2,349 | 1,767 | 1,577 | 1,821 | +12.8% | |
| Income before tax | 3,311 | 2,674 | 1,959 | 1,607 | 1,890 | +15.0% | |
| Net income | 2,856 | 2,323 | 1,798 | 1,322 | 1,705 | +13.8% | |
| Earnings per share | |||||||
| EPS (basic) | $8.00 | $6.54 | $5.12 | $3.72 | $4.79 | +13.7% | |
| EPS (diluted) | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 | +14.0% | |
| Share count (millions) | |||||||
| Weighted avg shares outstanding | 357 | 355 | 351 | 356 | 356 | +0.1% | |
| Weighted avg shares outstanding (diluted) | 363 | 362 | 357 | 362 | 366 | -0.2% | |
| Balance sheet highlights | |||||||
| Net debt | (3,065) | (1,881) | (2,750) | (1,581) | (1,204) | — | |
| Total debt | 303 | 146 | 0 | 0 | 87 | +36.6% | |
| Total investments | 5,865 | 7,051 | 4,593 | 5,165 | 7,356 | -5.5% | |
| Total stockholders' equity | 17,824 | 16,434 | 13,308 | 11,042 | 11,952 | +10.5% | |
| Total assets | 20,631 | 18,839 | 15,442 | 12,974 | 13,555 | +11.1% | |
| Cash flow highlights | |||||||
| Free cash flow | 2,491 | 1,304 | 750 | 958 | 1,736 | +9.4% | |
| Operating cash flow | 3,031 | 2,415 | 1,814 | 1,491 | 2,089 | +9.7% | |
| Capital expenditure | (540) | (1,111) | (1,064) | (532) | (353) | — | |
| Net cash from operating activities | 3,031 | 2,415 | 1,814 | 1,491 | 2,089 | +9.7% | |
| Additional fields | |||||||
| Accrued Expenses | 471 | 536 | 476 | 380 | 235 | +18.9% | |